Health: Multiple Sclerosis Debate
Full Debate: Read Full DebateDepartment: Department of Health and Social Care
Lord Roberts of Llandudno
Main Page: Lord Roberts of Llandudno (Liberal Democrat - Life peer)Department Debates - View all Lord Roberts of Llandudno's debates with the Department of Health and Social Care
(9 years, 10 months ago)
Lords ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Earl Howe
The noble Baroness is right that care plans have to be tailored to each individual patient. For those with serious neurological conditions, that is as important as for anyone. I do not have up-to-date information about what work NHS England is doing at the moment on this, but I am happy to write to her on the subject.
Lord Roberts of Llandudno (LD)
My Lords, how widely shared are these new medications? For instance, I know that some cancer medications are available to patients in England but not to patients in Wales. How widely is this information shared so that everyone can benefit, even if we are under the devolved Administrations?
Earl Howe
My noble friend will know that I cannot speak for the devolved Administrations, who have complete autonomy in their healthcare policies. I can say that a number of drugs have been recommended for use on the NHS for MS patients, including Tysabri, Gilenya, Aubagio and Lemtrada. However, it is ultimately for the devolved Administrations to decide whether they wish to have the same set of rules in place as we do in England.